News

Frequency Electronics Reports Impressive Q1 Growth for 2025

Frequency Electronics Reports Impressive Q1 Growth for 2025

Frequency Electronics Inc. Posts Strong First-Quarter FY2025 Results

Frequency Electronics, Inc. (NASDAQ: FEIM) reported a solid start to fiscal year 2025, with both revenue and earnings moving higher. For the quarter ended July 31, 2024, revenue came in at approximately $15.1 million, up from $12.4 million in the same period last year. That’s roughly 22% year-over-year growth—clear evidence that demand for the company’s solutions continues to strengthen.

Operating Income and Net Income

Profitability also improved. Operating income for the quarter was $2.4 million, compared with $2.1 million in the first quarter of the prior fiscal year. Net income was likewise $2.4 million, or $0.25 per diluted share, up from $2.0 million, or $0.22 per diluted share, a year ago. The step-up in both operating income and earnings per share reflects tighter execution and a more favorable mix of work.

CEO’s View on Momentum and Backlog

President and CEO Tom McClelland pointed to disciplined management and a resilient product portfolio as key drivers of the quarter’s performance. He noted the company ended the quarter with a $70 million backlog. While that’s slightly below the $78 million peak reported at the end of fiscal year 2024, it remains meaningfully higher than in prior years. In practical terms, the backlog signals sustained customer demand and provides visibility into upcoming production.

Financial Breakdown: Key Metrics

Revenue Mix and Trends

In the three months ended July 31, 2024, satellite payload programs generated approximately $8.3 million, or about 55% of consolidated revenue. That’s a notable jump from $4.9 million, or 39%, in the same quarter last year. Revenues from non-space U.S. Government/Department of Defense customers were about $6.3 million, representing roughly 42% of total revenue, compared with $6.9 million, or 55%, in the year-ago period. The shift underscores a larger contribution from space payload work this quarter while maintaining a significant base of U.S. Government/DOD activity.

Operating Activities and Cash Flow

Cash use improved meaningfully. Net cash used in operating activities was approximately $1.5 million for the quarter, better than the $2.8 million used in the prior-year period. The year-over-year reduction points to progress in cash management and operating efficiency.

Expected Future Developments

Leadership reiterated its focus on strengthening profitability and cash generation. McClelland emphasized delivering solutions that improve quality of life and safeguard national interests—work the company intends to pursue with the same discipline shown this quarter. Management expects continued momentum in new business activity through the remainder of the fiscal year, which ends on April 30, 2025.

Investor Call Announcement

Frequency Electronics scheduled a conference call for investors to discuss these results in greater detail, taking place on the day of the announcement. Participants can dial in using the provided numbers, and a replay and related materials will be available on the company’s website after the call.

About Frequency Electronics, Inc.

Frequency Electronics, Inc. designs and manufactures precision timing, frequency generation, and RF control products for both space and terrestrial applications. Its technologies support critical systems used by commercial, government, and military customers. Backed by ongoing research and development, the company’s offerings are built for accuracy and reliability—attributes that have defined its work for decades.

Frequently Asked Questions

What were Frequency Electronics’ revenues for the first quarter of 2025?

Revenue was approximately $15.1 million for the quarter ended July 31, 2024, up from $12.4 million in the same quarter last year—an increase of about 22%.

How much was the operating income reported?

Operating income was $2.4 million for the first quarter, compared with $2.1 million in the prior-year period, reflecting improved execution and mix.

What percentage of revenues came from satellite payloads?

Satellite payload revenues accounted for about 55% of consolidated revenue in the quarter, or roughly $8.3 million, up from 39% (about $4.9 million) a year earlier.

When is the investor conference call scheduled?

The investor call was scheduled for September 10, 2024, at 4:30 PM Eastern Time, with related materials to be posted on the company’s website after the call.

Who can be contacted for investor relations information?

Investor inquiries may be directed to Dr. Thomas McClelland, President and Chief Executive Officer, and Steven Bernstein, Chief Financial Officer.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 5

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 5

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading

Top 5 Most Recently Viewed Articles

Red Pine Unveils Exciting Gold Discoveries at Wawa Project

Updated Category News Views 177

Red Pine Exploration's Impressive Drilling Results Red Pine Exploration Inc. (TSXV: RPX, OTCQB: RDEXF) is thrilled to announce outstanding results from its ongoing drilling program at the Wawa Gold Project. This Canadian gold exploration company has executed a comprehensive drilling initiative, totaling 2,793 meters across three drill holes, aiming to unlock the full...

Continue Reading
Silver's Backwardation: What It Means for Investors Today

Updated Category News Views 447

Understanding Silver's Current Market Dynamics Recently, silver's futures market revealed a significant shift, entering a state of backwardation not seen for four decades. This phenomenon indicates that the short-term contract price is considerably higher than longer-term futures, reflecting a dramatic demand for immediate physical silver. The difference of $2.88...

Continue Reading
PGIM High Yield Funds Announce Monthly Distributions

Updated Category News Views 508

PGIM Funds Unveil Distribution Plans for Shareholders NEWARK, N.J.--PGIM High Yield Bond Fund, Inc. (NYSE: ISD), PGIM Global High Yield Fund, Inc. (NYSE: GHY), and PGIM Short Duration High Yield Opportunities Fund (NYSE: SDHY) have announced their monthly distributions for December 2024, January, and February 2025. This initiative signifies their commitment to delivering...

Continue Reading
Investors Urged to Act as Altimmune Faces Legal Challenges

Updated Category News Views 156

Important Legal Investigations Concerning Altimmune, Inc. Faruqi & Faruqi, LLP is currently investigating potential claims on behalf of investors who may have suffered financial losses related to Altimmune, Inc. (NASDAQ: ALT). Investors who acquired securities of Altimmune should pay close attention to this matter, as there are critical developments that could affect...

Continue Reading
Conejo Valley Unified Faces Lawsuits Over Assault Inaction

Updated Category News Views 6

Legal Scrutiny Hits Conejo Valley Unified In what feels like a never-ending cycle of educational mishaps, Conejo Valley Unified School District and its Westlake High School find themselves under the harsh spotlight of the legal system. Two lawsuits filed in Ventura County Superior Court are laying bare some serious accusations against them. Former students, using the...

Continue Reading